首页> 美国卫生研究院文献>Frontiers in Immunology >Anti-Rods/Rings: A Human Model of Drug-Induced Autoantibody Generation
【2h】

Anti-Rods/Rings: A Human Model of Drug-Induced Autoantibody Generation

机译:抗棒/环:药物诱导的自身抗体生成的人类模型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years, autoantibodies targeting subcellular structures described as the rods and rings pattern in HEp-2 ANA have been presented as a unique case of autoantibody generation. These rod and ring structures (RR) are at least partially composed of inosine monophosphate dehydrogenase type 2 (IMPDH2), and their formation can be induced in vitro by several small-molecule inhibitors, including some IMPDH2 inhibitors. Autoantibodies targeting these relatively unknown structures have been almost exclusively observed in hepatitis C virus (HCV) patients who have undergone treatment with pegylated interferon-α/ribavirin (IFN/RBV) combination therapy. To date, anti-RR antibodies have not been found in treatment-naïve HCV patients or in patients from any other disease groups, with few reported exceptions. Here, we describe recent advances in characterizing the RR structure and the strong association between anti-RR antibody response and HCV patients treated with IFN/RBV, detailing why anti-RR can be considered a human model of drug-induced autoantibody generation.
机译:近年来,针对亚细胞结构的自身抗体被描述为HEp-2 ANA中的杆和环模式,是自身抗体产生的独特案例。这些杆和环结构(RR)至少部分由2型肌苷单磷酸脱氢酶(IMPDH2)组成,它们的形成可以由几种小分子抑制剂(包括某些IMPDH2抑制剂)在体外诱导。在已经接受了聚乙二醇化干扰素-α/利巴韦林(IFN / RBV)联合治疗的丙型肝炎病毒(HCV)患者中,几乎只能观察到靶向这些相对未知结构的自身抗体。迄今为止,在未接受过治疗的HCV患者或任何其他疾病组的患者中均未发现抗RR抗体,只有少数报道例外。在这里,我们描述了表征RR结构的最新进展以及抗RR抗体应答与IFN / RBV治疗的HCV患者之间的强关联,并详细说明了为什么抗RR可以被认为是药物诱导的自身抗体生成的人类模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号